UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

Characterisation of patients referred to a tertiary-level inherited cardiac condition clinic with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC)

BMC cardiovascular disorders, 2023-01, Vol.23 (1), p.14-11, Article 14

2023

Volltextzugriff (PDF)

Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide

Europace (London, England), 2023-03, Vol.25 (3), p.1152-1161

2023

Volltextzugriff (PDF)

JavaCyte, a novel open-source tool for automated quantification of key hallmarks of cardiac structural remodeling

Scientific reports, 2020-11, Vol.10 (1), p.20074-20074, Article 20074

2020

Volltextzugriff (PDF)

Overexpression of VEGFα as a biomarker of endothelial dysfunction in aortic tissue of α-GAL-Tg/KO mice and its upregulation in the serum of patients with Fabry's disease

Frontiers in cardiovascular medicine, 2024-02, Vol.11, p.1355033-1355033

2024

Volltextzugriff (PDF)

Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes

The Journal of pharmacology and experimental therapeutics, 2002-10, Vol.303 (1), p.218

2002

Volltextzugriff (PDF)

Minimally invasive closed-chest ultrasound-guided substance delivery into the pericardial space in mice

Naunyn-Schmiedeberg's archives of pharmacology, 2013-03, Vol.386 (3), p.227-238

2013

Volltextzugriff (PDF)

Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study

Europace (London, England), 2009-10, Vol.11 (10), p.1338-1344

2009

Volltextzugriff (PDF)

Progression of definite and non-definite Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and risk of major adverse cardiac events

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Gene construction, expression and functional testing of an inotropic peptide from the venom of the black scorpion Hottentotta judaicus

Toxicon (Oxford), 2012-12, Vol.60 (8), p.1415-1427

2012

Volltextzugriff (PDF)

Pharmacist management of atrial fibrillation: a pilot educational intervention study

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Arrhythmogenic right ventricular cardiomyopathy: An update on pathophysiology, genetics, diagnosis, and risk stratification

Herzschrittmachertherapie & Elektrophysiologie, 2012-09, Vol.23 (3), p.186-195

2012

Volltextzugriff (PDF)

From cells to circulating biomarker: BMP10 is a myocyte-secreted peptide with potential to detect atrial fibrillation

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Genetic background, sex, age and pacing cycle length affect left atrial electrophysiology in Langendorff-perfused isolated murine hearts

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Of hammers and screws: renin–angiotensin–aldosterone system inhibition to prevent atrial fibrillation in patients with hypertension

European heart journal, 2014-05, Vol.35 (18), p.1169-1171

2014

Volltextzugriff (PDF)

Cross-sectional and longitudinal characterisation of cognitive function and outcomes in patients presenting to hospital with cardiovascular risk factors

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs : Antiarrhythmic and proarrhythmic effects

Circulation (New York, N.Y.), 1998-06, Vol.97 (25), p.2567-2574

1998

Volltextzugriff (PDF)

Identification of novel biomarkers for predicting atrial fibrillation outcomes in patients with cardiovascular risk factors

Europace (London, England), 2021-05, Vol.23 (Supplement_3)

2021

Volltextzugriff (PDF)

Natriuretic peptides predict future heart failure and cardiovascular death in an unselected population of patients presenting to hospital: interactions with atrial fibrillation

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Preclinical testing of drug-induced proarrhythmia: value of transgenic models

Cardiovascular & hematological agents in medicinal chemistry, 2007-10, Vol.5 (4), p.289

2007

Volltextzugriff (PDF)

P377Late sodium current as a promising drug target for treatment of atrial fibrillation?

Cardiovascular research, 2014-07, Vol.103 (suppl 1), p.S69-S69

2014

Volltextzugriff (PDF)

Dynamic changes of cardiovascular biomarkers after ablation for atrial fibrillation: observations from AXAFA-AFNET5

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Atrial endomysial fibrosis is associated with sex, atrial fibrillation, heart failure and age in cardiac surgery patients: results from the Catch-Me consortium

Europace (London, England), 2022-05, Vol.24 (Supplement_1)

2022

Volltextzugriff (PDF)

Drug-induced torsades de pointes — A form of mechano-electric feedback?

Cardiovascular research, 2007-11, Vol.76 (2), p.202-203

Fabritz, Larissa

2007

Volltextzugriff (PDF)

1272Effect of age, genetic background and experimental conditions on left atrial monophasic action potential duration, effective refractory period and activation time in Langendorff-perfused murine hearts

Europace (London, England), 2020-06, Vol.22 (Supplement_1)

2020

Volltextzugriff (PDF)

Etiological and molecular determinants of atrial endomysial fibrosis: results from the CATCH ME consortium

Europace (London, England), 2023-05, Vol.25 (Supplement_1)

2023

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(115)

Publikationsform

Artikel
(119)
Bücher
(1)

Sprache

Englisch
(118)
Japanisch
(14)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterisation of patients referred to a tertiary-level inherited cardiac condition clinic with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC)

Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide

JavaCyte, a novel open-source tool for automated quantification of key hallmarks of cardiac structural remodeling

Overexpression of VEGFα as a biomarker of endothelial dysfunction in aortic tissue of α-GAL-Tg/KO mice and its upregulation in the serum of patients with Fabry's disease

Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes

Minimally invasive closed-chest ultrasound-guided substance delivery into the pericardial space in mice

Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study

Progression of definite and non-definite Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and risk of major adverse cardiac events

Gene construction, expression and functional testing of an inotropic peptide from the venom of the black scorpion Hottentotta judaicus

Pharmacist management of atrial fibrillation: a pilot educational intervention study

Arrhythmogenic right ventricular cardiomyopathy: An update on pathophysiology, genetics, diagnosis, and risk stratification

From cells to circulating biomarker: BMP10 is a myocyte-secreted peptide with potential to detect atrial fibrillation

Genetic background, sex, age and pacing cycle length affect left atrial electrophysiology in Langendorff-perfused isolated murine hearts

Of hammers and screws: renin–angiotensin–aldosterone system inhibition to prevent atrial fibrillation in patients with hypertension

Cross-sectional and longitudinal characterisation of cognitive function and outcomes in patients presenting to hospital with cardiovascular risk factors

Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs : Antiarrhythmic and proarrhythmic effects

Identification of novel biomarkers for predicting atrial fibrillation outcomes in patients with cardiovascular risk factors

Natriuretic peptides predict future heart failure and cardiovascular death in an unselected population of patients presenting to hospital: interactions with atrial fibrillation

Preclinical testing of drug-induced proarrhythmia: value of transgenic models

P377Late sodium current as a promising drug target for treatment of atrial fibrillation?

Dynamic changes of cardiovascular biomarkers after ablation for atrial fibrillation: observations from AXAFA-AFNET5

Atrial endomysial fibrosis is associated with sex, atrial fibrillation, heart failure and age in cardiac surgery patients: results from the Catch-Me consortium

Drug-induced torsades de pointes — A form of mechano-electric feedback?

1272Effect of age, genetic background and experimental conditions on left atrial monophasic action potential duration, effective refractory period and activation time in Langendorff-perfused murine hearts

Etiological and molecular determinants of atrial endomysial fibrosis: results from the CATCH ME consortium

Suchergebnisse filtern